SOLESENCE, INC. — Form 8-K
Filed August 20, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 42/100
What the filing says
Solesence reported Q2 2026 revenue of $15.3M vs. $20.4M in Q2 2025 (down 25%), with net loss of $158K vs. net income of $3.2M year-over-year. The company identified and is correcting a historical inventory costing methodology issue related to indirect manufacturing cost allocation—a non-cash accounting matter that does not affect underlying operations or cash flow. Management projects full-year 2026 revenue will exceed 2025; as of Aug 17, 2026, shipped and on-hand orders totaled $64.9M vs. $60.0M in prior year.
Why this rating
Revenue decline (~$5.1M, 19% of $27.3M market cap) is material; accounting restatement signals control weakness. However, non-cash nature, management confidence in H2 recovery, and order momentum ($64.9M) limit downside. Moderate concern for small-cap.
See more from August 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.